NCT01017666 BIIB014 Effects on the Pharmacokinetics (PK) of Rosiglitazone, Warfarin, and Midazolam Status COMPLETED Phase PHASE1
NCT01017198 Effect of Food and Antacid on BIIB021 With Advanced Solid Tumors Status COMPLETED Phase PHASE1
NCT01004081 Hormone Receptor Positive Metastatic Breast Cancer (HR+ mBC) BIIB021 Plus Aromasin Schedule Finding Status COMPLETED Phase PHASE2
NCT00970580 A Study of BIIB022 in Combination With Paclitaxel and Carboplatin in Subjects With Non-Small Cell Lung Cancer Status COMPLETED Phase PHASE1
NCT00964288 Effect of GSK1014802 on Electrical Hyperalgesia and Threshold Tracking in Healthy Subjects Status TERMINATED Phase PHASE1
NCT00961766 Evaluate the Safety, Tolerability and Pharmacokinetics of BG00010 (Neublastin) Administered to Sciatica Participants Status COMPLETED Phase PHASE1
NCT00955396 Study to Investigate the Effect of GSK1014802 on Ambulatory Blood Pressure Status COMPLETED Phase PHASE1
NCT00937677 Effect of Tysabri in Patients With Relapsing-Remitting Multiple Sclerosis: A Follow-up Magnetization Transfer Imaging (MTI) Study Status COMPLETED Phase N/A
NCT00915577 Patient Satisfaction Study of Single-Use Autoinjector for the Delivery of Pre-Filled Avonex Syringe Status COMPLETED Phase PHASE3
NCT00913666 Pharmacodynamic Study to Better Understand the Therapeutic Response and Immunomodulatory Effects of Avonex in Multiple Sclerosis (MS) Patients and Healthy Volunteers Status COMPLETED Phase PHASE4
NCT00913250 A Bioequivalence Study of Serum Free Avonex and Serum Containing Avonex in Healthy Volunteers Status COMPLETED Phase PHASE1
NCT00908154 Safety, Tolerability and Pharmacokinetics of Repeat Doses of GSK1014802. Status COMPLETED Phase PHASE1
NCT00906399 Efficacy and Safety Study of Peginterferon Beta-1a in Participants With Relapsing Multiple Sclerosis Status COMPLETED Phase PHASE3
NCT00884481 Effects of Tysabri (BG00002) Over 12 Months on MS Related Fatigue in Participants With RRMS Status COMPLETED Phase N/A
NCT00876876 International, Multicenter, Open-Label and Randomized Withdrawal Study of Oral Lixivaptan in Heart Failure Patients With Chronic Hyponatremia Status WITHDRAWN Phase PHASE3
NCT00876798 A Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Tolerability of Oral Lixivaptan Capsules in Subjects With Euvolemic Hyponatremia Status COMPLETED Phase PHASE3